OKLO — Oklo Inc.

Summary of OKLO Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Operating Loss: $139.3 million, primarily due to payroll, business expenses, and professional fees.
• Loss Before Income Taxes: $110.2 million, including $29.1 million in interest and dividend income.
• Cash Used in Operating Activities: $82.2 million, adjusted to $69.2 million after accounting for prepaid capital project expenses, aligning with guidance of $65 million to $80 million.
• Cash and Marketable Securities: $1.4 billion at year-end, with an additional $1.182 billion raised in January 2026 through an ATM program.
• Guidance for 2026: Cash used in operating activities expected to rise to $80 million to $100 million, with capital expenditures projected between $350 million and $450 million.

2. Strategic Updates and Business Highlights

• Transition to Project Deployment: 2025 marked a shift from product development to active project deployment, including groundbreaking on the Aurora powerhouse at Idaho National Laboratory (INL).
• Key Partnerships: Secured a prepayment agreement with Meta for a 1.2-gigawatt power campus, enhancing project certainty and funding for fuel procurement.
• Acquisition: Completed the acquisition of Atomic Alchemy and made significant progress on the Groves radioisotope test reactor in Texas.
• Fuel Development: Advanced fuel capabilities, including fast-spectrum plutonium criticality experiments and the establishment of an advanced fuel center in Tennessee.
• Isotope Business: Progressed on the Idaho Radiochemistry Laboratory, which is expected to generate revenue in 2026.

3. Forward Guidance and Outlook

• 2026 Expectations: Anticipate increased capital expenditures to support multiple projects across power, fuel, and isotopes, with a focus on scaling operations and enhancing supply chains.
• Long-Term Strategy: Emphasis on building a vertically integrated nuclear platform that combines power generation, fuel production, and isotope services to unlock multiple revenue streams.

4. Bad News, Challenges, or Points of Concern

• Operating Losses: Continued significant operating losses raise concerns about cash management and the sustainability of operations without additional revenue streams.
• Regulatory Challenges: Potential delays in regulatory approvals and licensing processes could impact project timelines, particularly as the company navigates both DOE and NRC pathways.
• Market Competition: The presence of other sodium-cooled reactor developers, such as TerraPower, presents competitive pressures, especially in securing partnerships and contracts.

5. Notable Q&A Insights

• Commercialization Pipeline: The company is optimistic about its commercialization prospects, with Meta as a key anchor customer, potentially attracting other clients.
• CapEx Allocation: While specific project-level breakdowns were not provided, the focus remains on advancing projects at INL and in Ohio, with a significant portion of CapEx directed toward these initiatives.
• Regulatory Strategy: Discussions highlighted the importance of DOE authorization for faster project execution, with expectations for NRC to provide clearer pathways for licensing in the future.
• Fuel Availability: Questions about fuel for the Aurora-INL reactor were addressed, indicating ongoing efforts to secure necessary fuel supplies and manage procurement effectively.
• Criticality Timeline for Groves: Confidence was expressed in achieving the July 4 target for criticality at the Groves reactor, with logistical efforts underway to ensure timely completion.

This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, challenges, and insights from the Q&A session, providing a comprehensive overview of OKLO's current position and outlook.